Rugiet vs BlueChew (2026): Cost Per Dose, BlueChew GOLD, and the Apomorphine Question

Quick verdict: BlueChew is the budget pick – its compounded chewables start at $20 per month, or about $3.33 per dose, while Rugiet Ready runs $12.42 to $22.42 per dose on a monthly plan (both verified 2026). Rugiet is the pick if you specifically want a maximum-strength, multi-active sublingual with fully published pricing: its troche combines sildenafil, tadalafil, and apomorphine in a single dose. The closest BlueChew equivalent is BlueChew GOLD, a four-active sublingual tablet – and these two are the only mainstream ED products on the US market that contain apomorphine at all.

Rugiet vs BlueChew at a Glance (2026)

The table below compares Rugiet Ready against BlueChew’s three product lines. All four are compounded medications prescribed through telehealth, which means none is an FDA-approved finished drug product. All contain PDE5 inhibitors, so none can be taken with nitrates – the combination can cause a dangerous drop in blood pressure.

What Is Rugiet Ready?

Rugiet Ready is a compounded sublingual troche that combines three active ingredients – sildenafil, tadalafil, and apomorphine – in one dose using the company’s “RD-37” delivery format. The troche dissolves under the tongue in roughly 5 to 10 minutes and is taken about 30 minutes before activity. It is produced by a 503A compounding pharmacy, so it is not an FDA-approved finished product, though its individual PDE5 ingredients are the same actives found in FDA-approved Viagra and Cialis.

Rugiet is sold by MSB Holdings, Inc. of Austin, Texas, which holds a BBB A+ rating and has been BBB accredited since November 26, 2025, with 37 complaints closed in the last three years – mostly about auto-renewal and cancellation friction. It ships to 48 states (all except Alabama and Idaho), stores at room temperature, and has a shelf life of roughly 180 days. Rugiet is highly rated in our full assessment – see our Rugiet review and Rugiet cost breakdown for plan-by-plan detail.

What Is BlueChew (and BlueChew GOLD)?

BlueChew sells compounded chewable tablets in single-active tiers – sildenafil at 30 mg or 45 mg, or tadalafil at 6 mg or 9 mg – with plans from $20 to $120 per month depending on dose count (verified May 2026). BlueChew GOLD is different: it is a sublingual tablet, not a chewable, and it carries four actives – sildenafil, tadalafil, apomorphine, and oxytocin. BlueChew discloses apomorphine strengths of 2 mg, 3 mg, and 4 mg for GOLD, but as of August 2026 it does not publish GOLD’s price anywhere on its public site; pricing appears only after completing its intake quiz.

One regulatory note, stated plainly: on September 9, 2025, the FDA issued warning letter 716698 to Dermacare LLC dba BlueChew, citing marketing language that described its compounded products as containing the “same active ingredients” as Viagra and Cialis. The letter concerned how the products were advertised – compounded drugs cannot be marketed as equivalent to FDA-approved drugs – and did not report product safety findings, a recall, or a halt in operations. BlueChew continues to operate normally. For how BlueChew’s chewables stack up against other chewable brands, see our ED chewables comparison.

The Apomorphine Question: Why These Two Products Stand Alone

Rugiet Ready and BlueChew GOLD are, as of 2026, the only two mainstream ED products in the US that include apomorphine – no branded FDA-approved ED drug and no other major telehealth formulation carries it. That shared ingredient is the real reason these two products keep getting compared, and it deserves a clear-eyed explanation.

What does apomorphine add to an ED medication?

Apomorphine is a dopamine receptor agonist that works centrally – in the brain’s arousal pathways – rather than peripherally on blood vessels the way sildenafil and tadalafil do. The theory behind combining them is to address both the vascular side of an erection (PDE5 inhibitors) and the neurological arousal signal (apomorphine) in one dose. Despite the name, apomorphine is not an opioid and is chemically unrelated to morphine.

Has apomorphine ever been approved for ED?

No. Apomorphine is FDA approved for Parkinson’s disease, but it has never been approved for erectile dysfunction in the United States. A sublingual apomorphine product for ED called Uprima was pursued around 2000, but its US application was withdrawn and it never reached the American market. Its presence in Rugiet Ready and BlueChew GOLD is possible only because both are compounded products prescribed off-label at a clinician’s discretion.

What are apomorphine’s documented side effects?

In ED clinical trials at sublingual doses, apomorphine’s most common side effect was nausea, reported in 9.8% of patients versus 0.4% on placebo (PMID 11872034), along with dizziness, headache, and – rarely – syncope (fainting). Anyone considering either product should factor this in on top of standard PDE5 side effects such as flushing and congestion, and neither product should ever be combined with nitrates. Our Rugiet side effects and safety guide covers the full profile in depth, and most of it applies equally to GOLD’s apomorphine component.

Cost Comparison: Which Is Cheaper?

BlueChew is decisively cheaper per dose. Its chewables run $2.86 to $3.75 per dose across all tiers (verified May 2026), with the entry Active plan at $20 per month for six 30 mg sildenafil chewables – $3.33 each. Rugiet Ready costs $12.42 to $22.42 per dose on a 12-dose monthly plan (about $149 to $269 per month), falling to roughly $8.00 to $14.58 per dose on quarterly billing, with promotional first-order pricing occasionally reaching about $7.29 per dose (all verified June-August 2026; promo pricing does not persist on renewal).

• Cost per dose – Winner: BlueChew. Its most expensive tier ($3.75) is less than half of Rugiet’s best sustained quarterly rate (~$8.00), and less than a third of Rugiet’s entry monthly rate ($12.42).
• Lowest entry commitment – Winner: BlueChew. You can start at $20 per month versus roughly $149 per month for Rugiet’s monthly plan.
• Pricing transparency for the apomorphine formulas – Winner: Rugiet. Rugiet publishes full per-dose pricing for Rugiet Ready on its site, while BlueChew GOLD’s price is not shown publicly and only appears after the intake quiz (checked August 2026).

The caveat: this is not an identical-product price gap. BlueChew’s cheap tiers are single-active chewables; Rugiet’s price buys a three-active formulation. The honest apples-to-apples comparison would be Rugiet Ready versus BlueChew GOLD – and BlueChew’s decision not to publish GOLD pricing makes that comparison impossible to complete from public information.

Ingredients, Regulation, and Cancellation: The Remaining Categories

• Most actives in one dose – Winner: BlueChew GOLD, with four (sildenafil, tadalafil, apomorphine, oxytocin) to Rugiet’s three. Count is not a proxy for results, though – oxytocin’s benefit for erectile function is not established in clinical evidence, and each added active is an added side-effect source.
• Regulatory record – Winner: Rugiet. No FDA action names Rugiet or MSB Holdings, while Dermacare LLC dba BlueChew received the September 2025 FDA warning letter described above. To be fair to BlueChew, that letter addressed marketing language, not product quality or safety.
• Cancellation clarity – Winner: BlueChew, narrowly. Both companies have documented inconsistencies, but BlueChew’s is a single 24-hour vs 48-hour notice discrepancy, while Rugiet publishes three contradictory notice windows (24, 48, and 72 hours) across its Terms and help pages. If you subscribe to Rugiet, read our step-by-step Rugiet cancellation guide first and act on the longest window.

Who Should Choose Rugiet?

Rugiet fits men who have already tried single-active sildenafil or tadalafil with underwhelming results and want the strongest multi-active option whose price they can actually see before signing up. The sublingual troche format, roughly 30-minute onset, published per-dose pricing, and a clean regulatory record (no FDA action names the company) are its core advantages, and it is highly rated in our full Rugiet review. It requires a prescription through Rugiet’s telehealth process, is available in 48 states, and – like every PDE5 product – is strictly off-limits if you take nitrates.

Check Rugiet Pricing

Who Should Choose BlueChew?

BlueChew (bluechew.com) fits first-time users and budget-focused buyers. If you have never taken an ED medication, a $20-per-month single-active chewable is a lower-cost, lower-complexity starting point than any three-active formulation, and single-active dosing makes it easier to identify which ingredient suits you. BlueChew GOLD only makes sense to consider if you have already maxed out single actives and are comfortable requesting pricing through its quiz – and at that point it is worth comparing the quote directly against Rugiet’s published rates.

Bottom Line

BlueChew wins on price per dose ($2.86-$3.75 vs $12.42-$22.42 monthly), entry cost ($20 vs ~$149 per month), and marginally on cancellation clarity. Rugiet wins on pricing transparency for the apomorphine class and on regulatory record. Between the two apomorphine products themselves – the only two on the mainstream US market – Rugiet Ready is the one you can fully evaluate before checkout, which is why it remains our reference point for maximum-strength compounded ED treatment.

Check Rugiet Pricing

Frequently Asked Questions

Is Rugiet or BlueChew better?

Neither is universally better – BlueChew is better on price ($2.86-$3.75 per dose vs Rugiet’s $12.42-$22.42 monthly rate, verified 2026), while Rugiet is better if you want a multi-active sublingual with published pricing and no FDA actions naming the company. First-time users are usually better served starting with a cheap single-active BlueChew tier; men who need maximum strength should compare Rugiet Ready against BlueChew GOLD directly.

What is the difference between BlueChew GOLD and Rugiet?

Both are compounded sublinguals containing sildenafil, tadalafil, and apomorphine, but BlueChew GOLD adds a fourth active, oxytocin, while Rugiet Ready uses a troche format with its RD-37 delivery system. The practical difference is transparency: Rugiet publishes per-dose pricing publicly, while BlueChew shows GOLD pricing only after its intake quiz (as of August 2026).

Which is cheaper, Rugiet or BlueChew?

BlueChew is significantly cheaper – its chewables cost $2.86 to $3.75 per dose with plans from $20 per month (verified May 2026), while Rugiet Ready runs $12.42 to $22.42 per dose monthly, or about $8.00 to $14.58 per dose on quarterly billing (verified June-August 2026). Even Rugiet’s best promotional rate of about $7.29 per dose is roughly double BlueChew’s most expensive tier.

Do Rugiet and BlueChew have the same ingredients?

Only partially. BlueChew’s standard chewables contain a single active – sildenafil (30 or 45 mg) or tadalafil (6 or 9 mg) – while Rugiet Ready combines sildenafil, tadalafil, and apomorphine in one troche. BlueChew GOLD is the overlap point: it shares Rugiet’s three actives and adds oxytocin.

Is either Rugiet or BlueChew FDA approved?

No. Both are compounded products, so neither Rugiet Ready nor any BlueChew tablet is an FDA-approved finished drug, although sildenafil and tadalafil themselves are the actives in FDA-approved Viagra and Cialis. Separately, BlueChew’s parent company received an FDA warning letter in September 2025 over marketing language that implied equivalence to approved drugs; it addressed advertising claims, not product safety.

What is apomorphine and why is it in both products?

Apomorphine is a dopamine receptor agonist that acts on arousal pathways in the brain, unlike sildenafil and tadalafil, which act on blood flow. It is FDA approved for Parkinson’s disease but has never been approved for ED, and Rugiet Ready and BlueChew GOLD are the only two mainstream ED products that include it. In ED trials, its most common side effect was nausea (9.8% vs 0.4% on placebo), with dizziness and rare fainting also documented.

Can I take Rugiet or BlueChew with nitrates?

No. Every Rugiet and BlueChew product contains a PDE5 inhibitor (sildenafil, tadalafil, or both), and combining PDE5 inhibitors with nitrates can cause a severe, potentially life-threatening drop in blood pressure. Tell the prescribing clinician about all medications during the telehealth intake, especially any nitrate, alpha-blocker, or blood pressure drug.

Is BlueChew GOLD a chewable?

No – despite the brand name, BlueChew GOLD is a sublingual tablet that dissolves under the tongue, not a chewable like BlueChew’s standard sildenafil and tadalafil products. That puts it in the same delivery category as Rugiet Ready’s sublingual troche.

How do I cancel Rugiet or BlueChew?

BlueChew cancellations run through your online account, with a documented discrepancy between 24-hour and 48-hour notice requirements in its policy pages. Rugiet requires contacting support and publishes three conflicting notice windows – 24, 48, and 72 hours – so cancel at least 72 hours before renewal to be safe and follow our step-by-step Rugiet cancellation guide.

Sources

• FDA Warning Letter 716698, Dermacare LLC dba BlueChew (Sep 9, 2025): https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/warning-letters/dermacare-llc-dba-bluechew-716698-09092025 (accessed August 19, 2026)
• Apomorphine SL efficacy and safety in ED, PMID 11872034: https://pubmed.ncbi.nlm.nih.gov/11872034/ (accessed August 19, 2026)
• BBB Business Profile, Rugiet Health (MSB Holdings, Inc., Austin, TX): https://www.bbb.org/us/tx/austin/profile/health-products/rugiet-health-0825-1000199932 (accessed August 19, 2026)
• BBB Business Profile, BlueChew (Dermacare LLC, Chicago, IL): https://www.bbb.org/us/il/chicago/profile/health-and-wellness/bluechew-dermacare-llc-0654-90028066 (accessed August 19, 2026)
• Rugiet official site (pricing): https://rugiet.com/ (pricing verified June-August 2026)
• BlueChew official site (product lineup; GOLD pricing gated behind intake quiz): https://bluechew.com/ (accessed August 19, 2026)